logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11147855 B1

PDFFull Text
Date of Patent:
Oct. 19, 2021

Filed:

Dec. 18, 2019

Methods for treating glaucoma or ocular hypertension comprising delivery of prostaglandins to the vitreous humour

Applicant:

Cella Therapeutics, Llc, Miami, FL (US);

Inventors:

Rhett M. Schiffman, Laguna Beach, CA (US);

Lukas Scheibler, Laguna Beach, CA (US);

Assignee:

Cella Therapeutics, LLC, Miami, FL (US);

Attorneys:

Maschoff Brennan

Brent A. Johnson

David Old

Primary Examiner:

Kevin S Orwig

Int. Cl.
CPC ...
A61K 38/08 (2019.01); A61K 31/557 (2006.01); A61P 27/06 (2006.01); A61K 31/192 (2006.01); A61K 38/07 (2006.01); A61K 47/64 (2017.01); A61K 47/55 (2017.01); A61K 31/165 (2006.01); A61K 38/17 (2006.01); A61K 38/22 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 38/08 (2013.01); A61K 31/165 (2013.01); A61K 31/192 (2013.01); A61K 31/557 (2013.01); A61K 38/07 (2013.01); A61K 38/1796 (2013.01); A61K 38/22 (2013.01); A61K 45/06 (2013.01); A61K 47/55 (2017.08); A61K 47/64 (2017.08); A61K 47/6425 (2017.08); A61P 27/06 (2018.01);
Abstract

This disclosure relates to a drug delivery system comprising an intraocular pressure lowering agent, a neurotrophic agent, such as a CNTF compound, a C-type Natriuretic Peptide (CNP) compound, a Tie-2 agonist, a Natriuretic Peptide Receptor-B (NPR-B) compound, or an apoptosis signaling fragment inhibitor (FAS) or FAS-ligand (FASL) inhibitor, including any combination of these compounds and a sustained delivery component. Methods of treating a glaucoma or related conditions, medicaments, kits, uses and methods of manufacturing are also described.

Find Patent Forward Citations

Quick Actions:

Schiffman, Rhett. (2021). Methods for treating glaucoma or ocular hypertension comprising delivery of prostaglandins to the vitreous humour (U.S. Patent No. 11147855). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11147855

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…